Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Homology Medicines Inc (FIXX)

Homology Medicines Inc (FIXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Homology Medicines Inc ONE PATRIOTS PARK BEDFORD MA 01730 USA

www.homologymedicines.com P: 781-301-7277

Description:

Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.

Key Statistics

Overview:

Market Capitalization, $K 54,338
Enterprise Value, $K 15,068
Shares Outstanding, K 58,134
Annual Sales, $ 1,160 K
Annual Net Income, $ -112,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -32,950 K
EBIT, $ -123,820 K
EBITDA, $ -126,190 K
60-Month Beta -0.10
% of Insider Shareholders 16.10%
% of Institutional Shareholders 31.32%
Float, K 48,774
% Float 83.90%
Short Volume Ratio 0.26

Growth:

1-Year Return 2.71%
3-Year Return -90.28%
5-Year Return -96.92%
5-Year Revenue Growth -68.48%
5-Year Earnings Growth 9.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 03/12/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -2.28
EPS Growth vs. Prev Qtr 57.89%
EPS Growth vs. Prev Year 60.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 03/26/24

FIXX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -102.52%
Return-on-Assets % -74.91%
Profit Margin % -9,737.93%
Debt/Equity 0.00
Price/Sales 46.65
Price/Cash Flow N/A
Price/Book 0.74
Book Value/Share 1.53
Interest Coverage -1.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar